Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (151-160 of 194) with videos related to

Pageof 20
Sort By:
Cancer|December 12, 2022
Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissueTim Nestler, Lara Kremer, Melanie von Brandenstein, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 10, 2018
Websites on Bladder Cancer: an Appropriate Source of Patient Information?Johannes Salem, Pia Paffenholz, Christian Bolenz, et al.
Urology|September 7, 2012
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancerPhilip Rosen, David Pfister, Denise Young, et al.
Cancer|September 19, 2002
Improved outcomes in patients with osteogenic sarcoma of the head and neckSnehal G Patel, Paul Meyers, Andrew G Huvos, et al.
Clinical Biochemistry|October 12, 2011
Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasiaRena F Oezdemir, Nadine T Gaisa, Katharina Lindemann-Docter, et al.
Journal of Cellular and Molecular Medicine|January 15, 2021
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumoursWasco Wruck, Felix Bremmer, Mara Kotthoff, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Salvage re-irradiation for recurrent head and neck cancerNancy Lee, Kelvin Chan, Justin E Bekelman, et al.
Journal of Cancer Research and Clinical Oncology|October 7, 2025
Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumorsLaurenz Sperber, Melanie von Brandenstein, Carolina Kessler, et al.
Cancer|December 20, 2011
Selective radiotherapy for the treatment of head and neck Merkel cell carcinomaBenjamin Lok, Sabrina Khan, Robert Mutter, et al.
British Journal of Cancer|January 13, 2022
Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumoursTim Nestler, Priya Dalvi, Friederike Haidl, et al.
Pageof 20

Showing results (151-160 of 194) with videos related to

Sort By:
Pageof 20
Cancer|December 12, 2022
Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissueTim Nestler, Lara Kremer, Melanie von Brandenstein, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 10, 2018
Websites on Bladder Cancer: an Appropriate Source of Patient Information?Johannes Salem, Pia Paffenholz, Christian Bolenz, et al.
Urology|September 7, 2012
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancerPhilip Rosen, David Pfister, Denise Young, et al.
Cancer|September 19, 2002
Improved outcomes in patients with osteogenic sarcoma of the head and neckSnehal G Patel, Paul Meyers, Andrew G Huvos, et al.
Clinical Biochemistry|October 12, 2011
Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasiaRena F Oezdemir, Nadine T Gaisa, Katharina Lindemann-Docter, et al.
Journal of Cellular and Molecular Medicine|January 15, 2021
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumoursWasco Wruck, Felix Bremmer, Mara Kotthoff, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Salvage re-irradiation for recurrent head and neck cancerNancy Lee, Kelvin Chan, Justin E Bekelman, et al.
Journal of Cancer Research and Clinical Oncology|October 7, 2025
Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumorsLaurenz Sperber, Melanie von Brandenstein, Carolina Kessler, et al.
Cancer|December 20, 2011
Selective radiotherapy for the treatment of head and neck Merkel cell carcinomaBenjamin Lok, Sabrina Khan, Robert Mutter, et al.
British Journal of Cancer|January 13, 2022
Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumoursTim Nestler, Priya Dalvi, Friederike Haidl, et al.
Pageof 20